Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Andrew Hore
twitter
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.
Funds & Trusts
Seraphim Space IT set for lift off
IPO Analysis
Media Tech SPAC launches PrimaryBid offer
IPO Analysis
New AIM admission: Silver Bullet Data Services
IPO Analysis
New AIM admission: itim Group
Premium
New strategy outlined for Dignity
Funds & Trusts
Specialist Fund Segment admission: Literacy Capital
Premium
Victoria acquisition adds online expertise
IPO Analysis
New AIM admission: Victorian Plumbing
IPO Analysis
New AIM admission: Spectral MD
IPO Analysis
New AIM admission: Thor Explorations Ltd
Premium
NMCN secures refinancing from a familiar face
Premium
Dignity strategy to be unveiled at AGM
IPO Analysis
New premium listing: Made.com
Premium
Open Orphan finalises Poolbeg Pharma spin-off
Premium
Best of the Best share price slumps despite special dividend
Premium
Director dealing: Sportingbet founder tops up online gaming holding
Premium
boohoo sales comparatives get tougher
Premium
Revolting shareholders: Morrisons directors’ not thought to be good value
Premium
AB Traction adds to Driver stake
AQUIS
New Aquis admission: Clarify Pharma
Premium
JLEN NAV falls, but dividend remains attractive
Premium
FTSE 250 index constituents’ dividend attractions
IPO Analysis
New standard listing: Thungela Resources
IPO Analysis
Aquis to Main Market: ImperialX / CloudBreak Discovery
Premium
TIP: The AIM share preventing hospital infections
IPO Analysis
New AIM admission: Artisanal Spirits
Premium
Director dealings: Emmerson
AQUIS
New Aquis admission: TECC Capital
IPO Analysis
New AIM admission: Arecor Therapeutics
AQUIS
New Aquis admission: Pioneer Media Holdings Inc
Load more
Xpeng – the Tesla rival whose shares have rallied 315% in two months
23/11/2020
‘End of Austerity’ promise hashed out during PMQs
10/10/2018
Brexit: 5,000 City jobs could leave UK
10/10/2018
Advanced Oncotherapy shares soar after cancer treatment milestone
10/10/2018
Two reasons Travelodge backers can expect sleepless nights
24/07/2020